SIRNAOMICS

Sirnaomics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative drugs for indications with significant unmet medical needs in areas such as cancers, skin conditions, fibrosis-related diseases, antiviral and cardiometabolic diseases, and medical aesthetics. The company leverages its deep experience in RNA therapeutics and novel delivery platform technologies, primarily focusing on RNAi therapeutics. Sirnaomics has established a strong presence in both Asia and the U.S., with headquarters in both regions. The company's pipeline of products are built upon its proprietary delivery platforms for RNA-based therapeutics including a polypeptide nanoparticle delivery platform (PNP) and a GalNAc delivery platform.

Sirnaomics' mission is to become a fully-integrated international biopharmaceutical company. The company has made significant progress in its clinical development programs, including multiple Phase 1, Phase 2, and Phase 3 clinical trials, and has received orphan drug designations from the FDA for several of its programs. The company has also established strategic partnerships with other companies to further develop and commercialize its products. Sirnaomics is a leading player in the RNA therapeutics space with a strong commitment to developing innovative therapies for patients with unmet medical needs.

Sirnaomics offers employees flexibility with regard to their work schedules and lab access, particularly in light of the ongoing COVID-19 pandemic. These flexible arrangements are expected to continue in the foreseeable future and may even remain in place after the pandemic threat has subsided.

Sirnaomics offers a competitive employee benefits package that includes flexible work schedules and lab access, even after the pandemic subsides. They also provide a program that allows employees to care for their health and the health of their dependents.

Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company dedicated to discovering and developing innovative drugs for indications with significant unmet medical needs and large market opportunities, particularly in areas such as cancers, skin conditions, fibrosis-related diseases, antiviral and cardiometabolic diseases, and medical aesthetics. Their mission is to become a fully-integrated international biopharmaceutical company, leveraging their deep experience in RNA therapeutics and novel delivery platform technologies to rapidly bring these innovative drugs to patients.

Sirnaomics promotes a collegial and supportive work environment that values diversity, fosters professional development, and encourages innovation. The company emphasizes the importance of team members bringing their unique perspectives and expertise to fuel the development of innovative drugs for indications with significant unmet medical needs. Sirnaomics aims to create a dynamic environment where employees can contribute to the company's exciting future growth while enjoying the flexibility of on-site work schedules and access to competitive employee benefits.

Sirnaomics emphasizes diversity, equity, and inclusion as foundational to their success. They believe a team comprised of individuals from diverse backgrounds fosters unique perspectives, critical thinking, and enhanced program development. This commitment is reflected in their equal opportunity employment practices, flexible work schedules, and competitive benefits program, creating an inclusive and supportive environment for all employees.